Current discretion is extended till 6 January. However, FDA also introduced new framework that allows those with current temporary permits to extend it till 2025 to give them time to apply for permanent approval. All a2 has to do is apply to this new framework till end of December.
what a pleasant surprise for shareholders and not so much pleasant for those who opened big short positions on news from china recently
Current discretion is extended till 6 January. However, FDA also...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.36 |
Change
-0.065(1.01%) |
Mkt cap ! $4.561B | |||
| Open | High | Low | Value | Volume |
| $6.33 | $6.40 | $6.28 | $4.563M | 721.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 9324 | $6.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.36 | 3625 | 8 |
View Market Depth
| Last trade - 12.32pm 15/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |